EIF3A and pulmonary arterial hypertension: in vitro experiments by Hai-Tao Yang et al. demonstrated that silencing the gene for EIF3A reduced PDGF-triggered proliferation, arrested the cell cycle, and down-regulated the expression of proliferation-associated proteins in pulmonary artery smooth muscle cells, ultimately reducing their proliferation and improving PAH (28).